Article Content

Since 1977, the San Antonio Breast Cancer Symposium has aimed to provide state-of-the-art information on breast cancer research. And this year's conference, to be held Dec. 4-8, is no different.

Sabcs 2018 - Click to enlarge in new windowSABCS 2018. SABCS 2018

Attendees will have access to thousands of scientific abstracts encompassing the latest clinical, translational, and basic research. SABCS 2018 is a chance for you to enhance your practice through educational and networking opportunities. Check out highlights from the upcoming conference to help you make the most of your experience at SABCS.


Program Overview

Attendees will have access to a wide range of educational and career development programs covering the spectrum of breast cancer research and treatment.


The Plenary Lectures, which focus on the latest trends in breast cancer, will kick off the day of learning at SABCS:


* Plenary Lecture 1 (Wednesday, Dec. 5): Breast Tumor Evolution and Intratumor Heterogeneity - Insights From Single Cell Genomics


* Presenter: Nicholas E. Navin, PhD, MD Anderson Cancer Center, Houston


* Plenary Lecture 2 (Thursday, Dec. 6): Neoadjuvant Endocrine Therapy: The Times They Are A-Changing


* Presenter: Ingrid A. Mayer, MD, MSCI, Vanderbilt University Medical Center, Nashville



There is no shortage of educational sessions and workshops available to attendees highlighting the variety of areas in breast cancer research and therapeutics. For instance, the "Molecular Biology in Breast Oncology" workshop, which will be held on Tuesday, Dec. 4 and moderated by Carlos L. Arteaga, MD, includes discussions on novel targets, circulating tumor DNA analysis, the tumor microenvironment, and molecular heterogeneity of triple-negative breast cancer.


Topics that will be featured during the educational sessions, include:


* Twenty Years of Targeting HER2: Where Are We Now?


* Insights and Controversies in Metastasis Biology


* Late Recurrence in ER Positive Breast Cancer: Therapeutic Interventions and Biological Insights


* Metabolic Reprogramming in Breast Cancer


* Updates in the Treatment of Triple Negative Breast Cancer



SABCS 2018 is an opportunity to hear the varying perspectives from leaders in the field. On Friday, Dec. 7, attendees will be able to hear two experts, Daniel Hayes, MD, FASCO, FACP, and Harold Burstein, MD, PhD, debate the question, "Should All Women with Breast Cancer and Positive Lymph Nodes Receive Chemotherapy?"


During the Clinical Science Forum, held on Wednesday, Dec. 5, Judy E. Garber, MD, MPH, from Dana-Farber Cancer Institute, will lead a discussion on "Cancer Genetics: Updates for Breast Cancer Care." Topics to be highlighted include polygenic risk scores, genetic testing and results in diverse populations, and moderate penetrance mutations.


In addition to the many scientific programs, Career Devlopment Forums throughout the symposium offer attendees the opportunity to learn how to foster their professional growth and relationships with their peers.


To close the conference, attendees can participate in one of the highlights of SABCS, "Year in Review." This special session examines the top contributions, publications, and discoveries in breast cancer. Moderated by SABCS Co-Director C. Kent Osborne, MD, this discussion will feature experts from basic science, translational research, early-stage breast cancer, and metastatic disease.


Recognizing Excellence

Throughout the symposium, pioneers in the field will be recognized and given the opportunity to share their knowledge and experience.


Ian Smith, MD, FRCP, FRCPE, Professor of Cancer Medicine at The Royal Marsden and the Institute of Cancer Research in London, will receive the William L. McGuire Memorial Lecture Award presented by SABCS. On Wednesday, Dec. 5 at 11:15 a.m., he will deliver the lecture "Hold That Scalpel! Using the Tumor to Determine the Treatment."


Ann Partridge, MD, MPH, Professor of Medicine at the Dana-Farber Cancer Institute in Boston, is the recipient of the 2018 AACR Outstanding Investigator Award for Breast Cancer Research. Her lecture, "Breast Cancer in Young Women: Understanding Differences to Improve Outcomes," will be presented on Friday, Dec. 7 at 11:30 a.m.


The 2018 AACR Distinguished Lectureship in Breast Cancer Research will be presented to Zena Werb, PhD, Professor of Anatomy and Associate Director of Basic Science at the Helen Diller Family Comprehensive Cancer Center at the University of California, San Francisco. She will share her lecture, "What Can We Learn from Breast Cancers that Metastasize or Don't?" on Thursday, Dec. 6, at 11:30 a.m.


"These very deserving recipients are the reason SABCS remains a leading global educational resource in research and treatment of breast cancer," said Osborne. "Their lectures about their work fulfill our mission of providing state-of-the-art information to scientists and physicians focusing on breast cancer."


Don't Miss the Latest Research at #SABCS18!

Join Oncology Times in San Antonio! We will be providing live updates on the latest research throughout the conference. Follow us on Twitter (@OncologyTimes) and Facebook (@OncologyTimesNews) to learn about cutting-edge breast cancer breakthroughs!